Suchergebnisse - "Dejnirattisai, Wanwisa"

PubPharm (116)

31

The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 Beta (B.1.351) and other variants of concern in preclinical studies

enthalten in: bioRxiv.org | 2022

von Spencer, A. | Morris, S. | Ulaszewska, M. | +23

32

Accelerating Inhibitor Discovery With A Deep Generative Foundation Model: Validation for SARS-CoV-2 Drug Targets

enthalten in: arXiv.org | 2022

von Chenthamarakshan, V. | Hoffman, S. | Owen, C. | +17

33

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV

enthalten in: JCI insight | 2022

von Ogbe, A. | Pace, M. | Bittaye, M. | +55

34

The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies

enthalten in: EBioMedicine | 2022

von Spencer, A. | Morris, S. | Ulaszewska, M. | +23

35

Memory cytotoxic SARS-CoV-2 spike protein-specific CD4+ T cells associate with viral control

enthalten in: ResearchSquare.com | 2022

von Dong, T. | Liu, G. | Felce, S. | +24

36

Reduced neutralisation of SARS-COV-2 Omicron-B.1.1.529 variant by post-immunisation serum

enthalten in: bioRxiv.org | 2022

von Dejnirattisai, W. | Shaw, R. | Supasa, P. | +11

37

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001) : a phase 4, non-inferiority, single blind, randomised study

enthalten in: Lancet (London, England) | 2022

von Costa Clemens, S. | Weckx, L. | Clemens, R. | +44

CommentIn: Lancet. 2022 Feb 5;399(10324):496-497. - PMID 35074137

38

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

enthalten in: Cell | 2022

von Dejnirattisai, W. | Huo, J. | Zhou, D. | +170

UpdateOf: bioRxiv. 2021 Dec 22;:. - PMID 34981049

39

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum

enthalten in: Lancet (London, England) | 2022

von Dejnirattisai, W. | Shaw, R. | Supasa, P. | +12

CommentOn: Lancet. 2022 Jan 1;399(10319):36-49. - PMID 34883053

40

The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants

enthalten in: Cell host & microbe | 2022

von Liu, C. | Zhou, D. | Nutalai, R. | +28